Sandoz Company IP News and Updates

A “catch 22” is defined as a “dilemma or difficult circumstance from which there is no escape because of mutually...

CASE OF THE WEEK BioDelivery Sciences Int’l, Inc. v. Aquestive Therapeutics, Inc., Appeal Nos. 2019-1643, -1644, -1645 (Fed. Cir. Aug....

ALLERGAN SALES, LLC v. SANDOZ, INC. Before Prost, Newman, and Wallach.  Appeal from the United States District Court for the...

CASE OF THE WEEK Amgen Inc. v. Sandoz Inc., Appeal No. 2018-1551 (Fed. Cir. May 8, 2019) In an appeal...

  Federal Circuit Summary   Before Judges Reyna, Bryson, and Stoll.  Appeals from the Patent Trial and Appeal Board and...

CASE OF THE WEEK Data Engine Technologies, LLC v. Google LLC, Appeal No. 2017-1135 (Fed. Cir. Oct. 9, 2018) In...

Written by Jane Xia and Jing Liu, Ph.D. MILLENNIUM PHARMACEUTICALS, INC. v. SANDOZ INC (Fed. Cir. July 17, 2017) (NEWMAN,...

Written by Peter E. Heuser, Schwabe, Williamson & Wyatt, P.C. The Circuit issued only one precedential patent case this week,...

In the 2003 panel decision in Schering Corp. v. Geneva Pharm., Inc., the panel rejected “the contention that inherent anticipation...